XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income $ 1,136,438 $ 1,004,356 $ 827,706
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation expense 814,978 758,596 707,331
Amortization of deferred financing costs 8,432 7,462 7,454
Amortization of debt discount 2,786 2,681 1,880
Loss on extinguishment of debt, net 1,646 17,787 9,333
Amortization of stock-based compensation 33,864 25,505 21,603
Equity in loss (income) of, and return on, unconsolidated entities and noncontrolling interests, net of eliminations 5,255 (108) 8,673
Real estate casualty loss 0 1,723 0
Abandonment of development pursuits 5,599 685 9,262
Unrealized gain on terminated cash flow hedges 0 (2,654) (2,894)
Cash flow hedge losses reclassified to earnings 3,883 7,887 8,984
Gain on sale of real estate assets (598,741) (627,637) (346,041)
Gain on sale of for-sale condominiums (2,217) (3,110) (8,213)
(Decrease) increase in resident security deposits, prepaid expenses and other assets (7,167) 5,505 (28,675)
Increase in accrued expenses, other liabilities and accrued interest payable 17,176 4,492 3,212
Net cash provided by operating activities 1,421,932 1,203,170 1,219,615
Cash flows from investing activities:      
Development/redevelopment of real estate assets including land acquisitions and deferred development costs (921,203) (654,861) (843,907)
Acquisition of real estate assets (536,838) (771,692) 0
Capital expenditures - existing real estate assets (160,313) (142,688) (108,531)
Capital expenditures - non-real estate assets (14,392) (10,547) (28,505)
Increase (decrease) in payables for construction 9,080 (29,887) 1,474
Proceeds from sale of real estate, net of selling costs 934,117 850,230 619,773
Proceeds from the sale of for-sale condominiums, net of selling costs 117,266 124,532 202,033
Note receivable lending (29,352) (1,210) (258)
Note receivable payments 4,021 2,435 3,419
Distributions from unconsolidated entities 51,464 63,171 11,157
Investments in unconsolidated entities (14,269) (53,536) (36,088)
Net cash used in investing activities (560,419) (624,053) (179,433)
Cash flows from financing activities:      
Issuance of common stock, net 20,020 31,874 3,464
Repurchase of common stock, net 0 0 (183,876)
Dividends paid (889,607) (888,344) (883,212)
Issuance of mortgage notes payable 0 0 51,000
Repayments of mortgage notes payable, including prepayment penalties (43,332) (109,562) (126,712)
Issuance of unsecured notes 348,565 1,098,643 1,296,581
Repayment of unsecured notes (100,000) (462,147) (958,680)
Payment of deferred financing costs (14,301) (8,864) (11,277)
Receipt (payment) for termination of forward interest rate swaps 26,869 4,751 (25,135)
Acquisition of/payments to noncontrolling interest (997) (55) (68)
Payments related to tax withholding for share-based compensation (16,989) (13,463) (14,917)
Distributions to DownREIT partnership unitholders (48) (48) (48)
Distributions to joint venture and profit-sharing partners (376) (306) (384)
Preferred interest obligation redemption and dividends (860) (1,340) (1,000)
Net cash used in financing activities (671,056) (348,861) (854,264)
Net increase in cash, cash equivalents and cash in escrow 190,457 230,256 185,918
Cash, cash equivalents and cash in escrow, beginning of year 543,788 313,532 127,614
Cash, cash equivalents and cash in escrow, end of year 734,245 543,788 313,532
Cash paid during the year for interest, net of amount capitalized 212,241 203,773 196,848
Supplemental Cash Flow Information      
Cash and cash equivalents 613,189 420,251 216,976
Cash in escrow 121,056 123,537 96,556
Cash, cash equivalents and cash in escrow shown in the Consolidated Statements of Cash Flows $ 734,245 $ 543,788 $ 313,532